Targeting of SLC25A22 boosts the immunotherapeutic response in KRAS-mutant colorectal cancer.
Zhou Q, Peng Y, Ji F, Chen H, Kang W, Chan LS, Gou H, Lin Y, Huang P, Chen D, Wei Q, Su H, Liang C, Zhang X, Yu J, Wong CC.
Zhou Q, et al. Among authors: chan ls.
Nat Commun. 2023 Aug 4;14(1):4677. doi: 10.1038/s41467-023-39571-6.
Nat Commun. 2023.
PMID: 37542037
Free PMC article.